# Clinical Study of Decitabine and Paclitaxel Combination Therapy

> **NCT03282825** · PHASE1 · UNKNOWN · sponsor: **Dong Wha Pharmaceutical Co. Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT03282825
- **Lead sponsor:** Dong Wha Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-28
- **Primary completion:** 2018-02
- **Final completion:** 2018-05
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282825, "Clinical Study of Decitabine and Paclitaxel Combination Therapy". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03282825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*